COMMUNIQUÉS West-GlobeNewswire

Aleafia Health Secures Outdoor Cultivation Licence, Commences Planting of First Outdoor Crop
10/06/2019
13,000 Starter Clones Already on-site at Port Perry Facility First Crop Underway With Plants now in the Ground Company’s Licensed Cultivation Area Increases from 22,000 sq. ft. to 314,000 sq. ft. Facility Expected to [...]
Issue of Equity on Exercise of Options
10/06/2019
Cambridge, UK and Indianapolis, US – 10 June 2018: Acacia Pharma Group plc (the "Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting [...]
MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity
10/06/2019
Multi-center 1,955 patient study published in the Journal of Urology IRVINE, CA, and HERSTAL, BELGIUM - Jun 10, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today [...]
MDxHealth (R) :
10/06/2019
Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.
10/06/2019
Basel, 10 June 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that they have each received a request for additional information and documentary material ( [...]
EnvoyAI Made Available to Over 200 UK Healthcare Locations
10/06/2019
LIVERPOOL, United Kingdom, June 10, 2019 (GLOBE NEWSWIRE) -- Advanced visualization and artificial intelligence (AI) technology provider, TeraRecon, today announced that it has reached agreement with Insignia Medical [...]
Photo Alert: Official photo for Montreal Canadiens star and JDRF National Spokesperson, Max Domi, walking with thousands of Montrealers to find a cure for type 1 diabetes at the Sun Life Walk to Cure Diabetes for JDRF
09/06/2019
MONTREAL, June 09, 2019 (GLOBE NEWSWIRE) -- On Sunday, June 9, 2019 at the Centre de la nature de Laval, Montreal Canadiens’ centre and JDRF National Spokesperson Max Domi joined thousands of Montrealers at the 2019 [...]
MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions
09/06/2019
WESTLAKE VILLAGE, Calif., June 09, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from three different studies of Afrezza® (insulin human) Inhalation Powder were released at the [...]
Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments
09/06/2019
Soliqua ® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments Patients switched to Soliqua reached an average blood sugar below the American Diabetes Association [...]
Les résultats de phase III de Soliqua® montrent une baisse significative de la glycémie sanguine comparativement à des traitements par agoniste des récepteurs GLP-1
09/06/2019
Les résultats de phase III de Soliqua ® montrent une baisse significative de la glycémie sanguine comparativement à des traitements par agoniste des récepteurs GLP-1 Les patients passés sous Soliqua ont obtenu un taux [...]
Medtronic Initiates Pivotal Trial for Next-Generation Guardian(TM) Continuous Glucose Monitoring Sensor
08/06/2019
DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has initiated the company's pivotal trial for its next-generation Guardian(TM) continuous glucose [...]
Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
08/06/2019
DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its Bluetooth® enabled MiniMed( [...]
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks
08/06/2019
Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance ® and Victoza ® San Francisco, US, 8 June 2019 - [...]
All-female cohort of community leaders raises more than $575,000 for annual Rescue in the Rockies for STARS
08/06/2019
CALGARY, Alberta, June 07, 2019 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service (STARS) is pleased to announce that the 2019 edition of its flagship fundraiser, Rescue in the Rockies raised more than $575,000. [...]
Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management
08/06/2019
DUBLIN and PALO ALTO, Calif. - June 7, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and Tidepool, a 501(c)(3) nonprofit organization dedicated to making diabetes data [...]
Adamas Announces New Employment Inducement Grant
07/06/2019
EMERYVILLE, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted five new employees the option [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2019
BURLINGTON, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to 10 new employees consisting of an aggregate of 25,250 stock options and 4,350 [...]
Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan
07/06/2019
TORONTO, June 07, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) wishes to clarify the nature of the supply arrangement by which Pharmadrug Production GmbH (“ Pharmadrug ”) is [...]
Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
07/06/2019
SANTA BARBARA, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously announced underwritten [...]

Pages